The historical rank and industry rank for Emmaus Life Sciences's PB Ratio or its related term are showing as below:
During the past 13 years, Emmaus Life Sciences's highest PB Ratio was 33.53. The lowest was 1.22. And the median was 4.90.
EMMA's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.48 * Ranked among companies with meaningful PB Ratio only.
During the past 3 years, the average Book Value Per Share Growth Rate was -44.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Emmaus Life Sciences was 85.80% per year. The lowest was -484.50% per year. And the median was -8.10% per year.
Back to Basics: PB Ratio
Emmaus Life Sciences PB Ratio Historical Data
The historical data trend for Emmaus Life Sciences's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Emmaus Life Sciences's PB Ratio
For the Biotechnology subindustry, Emmaus Life Sciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Emmaus Life Sciences's PB Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Emmaus Life Sciences's PB Ratio distribution charts can be found below:
* The bar in red indicates where Emmaus Life Sciences's PB Ratio falls into.
Emmaus Life Sciences PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Emmaus Life Sciences (OTCPK:EMMA) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Emmaus Life Sciences PB Ratio Related Terms
Thank you for viewing the detailed overview of Emmaus Life Sciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Emmaus Life Sciences (Emmaus Life Sciences) Business Description
Emmaus Life Sciences Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of new treatments and therapies primarily for rare and orphan diseases. The company's commercial product is Endari, an oral pharmaceutical grade L-glutamine treatment indicated to reduce acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Its products in the pipeline include Diverticulosis and Cell Sheet Engineering.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EMMA has been successfully added to your 